News
Stem cell: $137 million buys more clinical trials, shared labs, research
A laboratory scientist uses a pipette to manipulate stem cells. (Photo: Vshivkova, via Sutterstock)It was a $137 million day for the Golden State’s stem cell agency — no small event even for an enterprise that is backed by billions. The scientific scope covered by the $137 million was impressive. It ranged from bolstering the vaunted Alpha Clinic Network initiated around the state by the California Institute for Regenerative Medicine (CIRM), as the agency is legally known, to raising the number of CIRM’s clinical trials to 83.